| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9385652 | Respiratory Medicine | 2005 | 9 Pages |
Abstract
Delivery of bronchodilators by Respimat® SMI is safe with regard to paradoxical bronchoconstriction during chronic use in patients with asthma or COPD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Rick Hodder, Demetri Pavia, Helen Dewberry, Karen Alexander, Philippe Iacono, Hans Ponitz, Ekkehard Beck,